Group 4 Created with Sketch.

Best Michael Chernew Interviews on Podcasts or Audio about Michael

Listen to audio about Michael Chernew. Browse for Michael Chernew interviews, guest appearances, and call-ins. Make snippets of Michael talking to create audio highlights to share with your friends or embed in related blog posts. Continue Reading >> Listen to audio about Michael Chernew. Browse for Michael Chernew interviews, guest appearances, and call-ins. Make snippets of Michael talking to create audio highlights to share with your friends or embed in related blog posts. << Show Less
interviews
guests
call-ins
appearances
Playlist
Vurbl People Audio Intro Listen to this compilation of insightful interviews, quotes, commentary, news, and more surrounding some of the most well-known public figures. You can also use Vurbl's snippet tool to clip and share your favorite moments with friends, family, and audio creators.
How Waste in Healthcare Can Be an Asset in APMs, with Michael Chernew, PhD There is a lot of avoidable waste in the basic delivery of care, but this waste is actually an asset for alternative payment models (APMs). Unlike the fee-for-service model that discourages eliminating waste and low-value care because it loses money, APMs can get paid to eliminate that same waste and improve healthcare quality, says health economist @Michael_Chernew, PhD, professor of #healthcare policy at @harvardmed school, and chair of MEDPAC @medicarepayment. In a timely interview with APG President and CEO @DonCrane, Professor Chernew talks about the premise of his recent JAMA article, “A Path Forward for Alternative Payment: Build a Portfolio Not a Garden.” @AmerPhysGrps #Medicare #valuebasedcare
What Is and Is Not in Trump’s Drug Pricing Plan: An Interview With Dr Michael Chernew Creators of President Donald Trump’s blueprint to control drug prices, American Patients First, say it represents real reform. Critics see a pulled punch to the pharmaceutical industry.

Mary Caffrey, the managing editor of The American Journal of Managed Care’s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission.

Read more:
Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen
Azar Stumps for Plan to Hold Down Prescription Drug Costs: www.ajmc.com/focus-of-the-week/azar-stumps-for-plan-to-hold-down-prescription-drug-costs
Trump Targets Drug Prices, Right-to-Try in State of the Union: www.ajmc.com/newsroom/trump-targets-drug-prices-righttotry-in-state-of-the-union
​​​​​​​Will Trump Take Steps to Rein in Drug Prices?: www.ajmc.com/focus-of-the-week/will-trump-take-steps-to-rein-in-drug-prices
Talking Health Care Costs and Value-Based Insurance with Harvard Professor Michael Chernew Katy Spangler, the American Benefits Council’s senior vice president, health policy, talks to Harvard Medical School Professor Michael Chernew, PhD, about health care costs, the promise of value-based insurance and what it all has to do with peanut butter and jelly.
Healthcare Policy and Payment Reform - Michael Chernew "Public policy and managerial innovation is less about health and more about money (taxes)," says Michael Chernew, Leonard D. Schaeffer Professor of Health Care Policy, Harvard Medical School. So how do we slow spending growth? Payment reform, benefit design, competition/managed care, organization of medical practice, and wellness are all factors that Chernew suspects will play a key role. Jacob Turmell, DNP, RN, NP-C, ACNS-BC, CCRN-CMC, is Vice President of MedAxiom Consulting.For more information, contact: HeartTalk@medaxiom.com or visit https://www.medaxiom.com.
What Is and Is Not in Trump’s Drug Pricing Plan: An Interview With Dr Michael Chernew Creators of President Donald Trump’s blueprint to control drug prices, American Patients First, say it represents real reform. Critics see a pulled punch to the pharmaceutical industry.

Mary Caffrey, the managing editor of The American Journal of Managed Care’s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission.

Read more:
Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen
Azar Stumps for Plan to Hold Down Prescription Drug Costs: www.ajmc.com/focus-of-the-week/azar-stumps-for-plan-to-hold-down-prescription-drug-costs
Trump Targets Drug Prices, Right-to-Try in State of the Union: www.ajmc.com/newsroom/trump-targets-drug-prices-righttotry-in-state-of-the-union
​​​​​​​Will Trump Take Steps to Rein in Drug Prices?: www.ajmc.com/focus-of-the-week/will-trump-take-steps-to-rein-in-drug-prices